by ReNewVax | May 5, 2023 | News
We’re thrilled to announce that ReNewVax has been shortlisted as one of the finalists to present a pitch at the 2023 BIO International Convention in Boston, Massachusetts. Taking place from 5th –8th June, the BIO International Convention is the world’s largest...
by ReNewVax | May 5, 2023 | News
Our Chief Scientific Officer Dr. Marie O’Brien was invited to appear on The Northern Agenda’s second birthday podcast! This episode saw hosts Rob Parsons and Dan McLaughlin discuss the last two years in Northern politics and ask whether the North is still a priority...
by ReNewVax | Apr 28, 2023 | News
World Immunization Week Q&A with Dr Marie O’Brien World Immunization Week, celebrated in the last week of April, aims to highlight the collective action needed to protect people from vaccine-preventable diseases. Here, our chief scientific officer Dr Marie...
by ReNewVax | Apr 26, 2023 | News
Our chief scientific officer Dr Marie O’Brien is featured in the April/May edition of Laboratory News discussing ReNewVax’s RVX-001 pneumococcal vaccine program. In the article, Dr O’Brien explores how we are deploying novel platform technology for vaccine design...
